Envoy Medical, Inc. Class A Common Stock
COCH Real Time Price USDRecent trades of COCH by members of U.S. Congress
---
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes in COCH holdings by institutional investors
Quarterly net insider trading by COCH's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More about Alpha -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More about Annual Standard Deviation -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More about Annual Volatility -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More about Beta -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More about CAGR -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More about Information Ratio -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More about Max Drawdown -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More about Sharpe Ratio -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More about Treynor Ratio -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
-
$20,000 Oct 19, 2026 Issue: Medicare/Medicaid
-
$10,000 Jan 20, 2026 Issue: Medicare/Medicaid
-
$10,000 Oct 17, 2025 Issue: Medicare/Medicaid
-
$5,000 Jul 18, 2025 Issue: Medicare/Medicaid
-
$80,000 Jan 17, 2025 Issue: Medicare/Medicaid
-
$40,000 Jan 16, 2025 Issue: Health Issues
-
$50,000 Oct 18, 2024 Issue: Medicare/Medicaid
-
$60,000 Oct 16, 2024 Issue: Health Issues
-
$120,000 Jul 19, 2024 Issue: Medicare/Medicaid
-
$50,000 Jul 17, 2024 Issue: Health Issues
-
$70,000 Jan 19, 2024 Issue: Medicare/Medicaid
-
$50,000 Oct 19, 2023 Issue: Medicare/Medicaid Defense Budget/Appropriations
Former government officials who have lobbied for COCH
8 former government officials from 5 congressional offices at 2 lobbying firms have lobbied for COCH, most recently Oct 19, 2026.
-
Patricia Deloatche Senate Health Policy Director, Sen Orrin Hatch; Chief of Staff, Legislative Director, Legislative Assistant, Rep Mike Billirakis -
Travis Norton Senate New Counsel, Sen. Tim Scott; Staff Dir, Senate Banking Subcomm. on Housing, Transportation, and Community Develop; General Counsel & Parliamentarian, House Financial Services Comm; General Counsel & Parliamentarian, House Judiciary Comm -
Adam Steinmetz House New Policy Advisor - Committee on the Budget, United States House of Representatives
-
Nadeam Elshami House New CoS, Dem. Ldr Pelosi; Comms.Dir/Sr. Adv., Dem.Ldr Nancy Pelosi; Dep. Comms. Dir/Sr. Adv., Speaker Pelosi; Sr. Comms. Adv./Dep. Comms. Dir/Spokesman/Natl Press Sec, Sen Durbin; Dep. CoS/Comms Dir/Press Sec, Rep Schakowsky; Dep Press Sec, Sen Boxer -
Emily Felder Congress New Director of the Office of Legislation, CMS; Counsel, House Energy and Commerce Committee; Counsel, Senate Committee on Homeland Security and Government Affairs; Counsel, House Oversight and Government Reform Committee
-
Jonathan Towers Congress New Staff Dir, Senate Vet Affairs, GOP Staff; Staff Dir, House Vet Affairs, GOP; Dep. Staff Dir, House Vet Affairs, GOP; Sr Health Policy Advisor, Senate Vet Affairs, GOP; Sr Prof Staff Mem. Senate Vet Affairs, GOP; Prof Staff Mem Senate Vet Affairs, GOP
-
Lauren Mish House New Intern, Rep. Brian Fitzpatrick (PA-01); Intern, Department of Health and Human Services in the Office of Global Affairs " -
Tracey Laturner House Professional Staff, U.S. House Appropriations Committee; Administrative Aide, U.S. House Appropriations Committee; Scheduler, Office Manager U.S. House of Representatives Congressman Jim Bunn
COCH Estimated quarterly lobbying spending
COCH Revenue by Segment or Geography
New COCH patent grants
Federal grants, loans, and purchases
Estimated quarterly amount awarded to COCH from public contracts
Recent insights relating to COCH
Recent picks made for COCH stock on CNBC
ETFs with the largest estimated holdings in COCH
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $COCH stock a Buy, Sell, or Hold?
- What is the price target for $COCH stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $COCH stock?
- Who owns the most shares of $COCH stock?
- What funds own $COCH stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view COCH Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.
- Address White Bear Lake, MN
- Market Cap 51.2 million
- Employees 47
- Industrial Classification Orthopedic, Prosthetic & Surgical Appliances & Supplies
Envoy Medical, Inc. Class A Common Stock (COCH) Historical Stock Prices
Daily open, high, low, close, adjusted close and volume for Envoy Medical, Inc. Class A Common Stock (COCH).
Quiver Premium charts COCH's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.
Upgrade to Premium| Date | Open | High | Low | Close | Adj. Close | Volume |
|---|
Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.
The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.
Explore the Quiver APIWe estimate that -- received a compensation of -- in --, making them the highest paid executive at COCH, per a recent SEC DEF 14A filing.
|
Name
|
Role
|
Salary
|
Bonus
|
Stock/Option Awards
|
Total Compensation
|
|---|